Kazia Therapeutics

IPO

Kazia Therapeutics, ASX: KZA, biotechnology

About

Kazia Therapeutics is an Australian oncology company developing innovative cancer drugs, with its lead program paxalisib targeting brain tumors.

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

Biopharmaceutical services company

Specialty pharmaceutical company

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...

Global full-service clinical research organization (CRO) and scientific advisory partner for biot...

Global clinical research organization specializing in early-stage clinical trials and bioanalytic...